Comparative immuno‐profiling of proliferative and disordered proliferative endometrium in anovulatory abnormal uterine bleeding
This study found no significant differences in CD4, CD8, CD56, or CD68 immune cell counts between proliferative and disordered proliferative endometrium in women with anovulatory abnormal uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study compared immune cell profiles in endometrial biopsies from 73 women with anovulatory abnormal uterine bleeding (AUB), classifying tissue as proliferative versus disordered proliferative endometrium (DPE). Using immunohistochemistry, the authors quantified CD4+ helper T cells, CD8+ cytotoxic T cells, CD56+ natural killer cells, and CD68+ macrophages across high-power fields, and found no statistically significant differences in immune marker counts or several clinical parameters between the two histologic groups. Correlation analyses instead showed significant positive associations among immune markers (e.g., CD4 with CD8, CD8 with CD68, and CD4 with CD56), with CD56 negatively correlated with BMI and positively correlated with bleeding duration. The paper concludes that local immune infiltration may not substantially differ between proliferative and DPE, while noting that larger studies and functional immune profiling are needed to detect subtle differences. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,591 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Objective
Methods
Results
Conclusion
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health 2022
- Health-related quality of life and economic burden of abnormal uterine bleeding 2009
- Imaging the Endometrium: Disease and Normal Variants 2001
- Identification of genes differentially expressed in menstrual breakdown and repair 2016
References (37)
- Health-related quality of life and economic burden of abnormal uterine bleeding via openalex
- Identification of genes differentially expressed in menstrual breakdown and repair via openalex
- Imaging the Endometrium: Disease and Normal Variants via openalex
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health via openalex
- doi:10.1016/j.autrev.2011.11.023 via openalex
- doi:10.1586/eci.11.49 via openalex
- doi:10.3389/fimmu.2020.00245 via openalex
- doi:10.1046/j.1365-2265.2001.01432.x via openalex
- doi:10.1002/j.2205-0140.2015.tb00020.x via openalex
- W1591382993 via openalex
- W1932709689 via openalex
- doi:10.1053/j.semdp.2021.12.001 via openalex
- doi:10.1002/dc.23010 via openalex
- doi:10.1016/j.yobg.2011.06.054 via openalex
- doi:10.1172/jci.insight.85560 via openalex
- doi:10.1016/j.maturitas.2008.12.018 via openalex
- doi:10.1210/en.2005-1153 via openalex
- doi:10.1007/s13224-011-0047-2 via openalex
- doi:10.1016/j.jri.2014.12.006 via openalex
- doi:10.1158/1055-9965.epi-05-0493 via openalex
- W6684115200 via openalex
- W6810698783 via openalex
- doi:10.1016/bs.ircmb.2022.03.011 via openalex
- doi:10.1016/j.patol.2024.05.005 via openalex
- doi:10.3389/fimmu.2023.1109122 via openalex
- doi:10.1093/humupd/dmw042 via openalex
- doi:10.4049/jimmunol.1300958 via openalex
- doi:10.4110/in.2015.15.1.16 via openalex
- doi:10.1093/humrep/det398 via openalex
- doi:10.1093/oxfordjournals.humrep.a137430 via openalex
- doi:10.1016/j.pharmthera.2023.108526 via openalex
- doi:10.1016/j.lfs.2022.120503 via openalex
- doi:10.1159/000320336 via openalex
- doi:10.3390/cancers11040573 via openalex
- doi:10.32614/r.manuals via openalex
- doi:10.1097/aog.0b013e3181e93330 via openalex
- doi:10.1002/jum.15880 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T11:25:47.971343+00:00